Neovia Oncology
Neovia Oncology LLC is a US-based clinical stage pharmaceutical company dedicated to developing innovative cancer treatments that address the most difficult aspects of cancer, including drug resistance and side effects. Inspired by personal experiences and driven by scientific innovation, Neovia aims to improve quality of life for cancer patients through advanced combination therapies.
Industries
medical
oncology
pharmaceutical
Nr. of Employees
small (1-50)
Products
Lead small‑molecule combination therapeutic for drug‑resistant solid tumors
A structurally linked small‑molecule combination candidate developed to simultaneously target multiple cancer cell pathways; selected from high‑throughput screening and advanced to Phase I clinical testing for late‑stage, drug‑resistant solid tumors.
Lead small‑molecule combination therapeutic for drug‑resistant solid tumors
A structurally linked small‑molecule combination candidate developed to simultaneously target multiple cancer cell pathways; selected from high‑throughput screening and advanced to Phase I clinical testing for late‑stage, drug‑resistant solid tumors.
Expertise Areas
- Phase I clinical development
- Oncology drug discovery and development
- Combinatorial medicinal chemistry and linker design
- Preclinical toxicology and safety assessment
Key Technologies
- Combination small‑molecule chemistry
- Linker chemistry
- High‑throughput combinatorial screening
- Preclinical toxicity assays